Cardiovascular benefits In November 2023, results from the Semaglutide and cardiovascular outcomes in obesity without diabetes (SELECT) trial, funded by Novo Nordisk, revealed that non-diabetic, overweight adults taking semaglutide for more than three years had a 20% lower risk of heart attack, stroke or death resulting from cardiovascular disease[3]
By sticking to these tips and making treatment fit each persons needs, we can help them get the best results from B12 therapy
What Clinicians Should Tell Patients Right Now The following decision framework summarizes a practical clinical approach to retatrutide and sexual health counseling, based on existing mechanistic evidence and Phase 2 data, while Phase 3 data are awaited
Arvat E, Maccagno B, Ramunni J, Di Vito L, Broglio F, Deghenghi R, Camanni F, Ghigo E
[8] Members filling prescriptions after 1/1/2026 may be responsible for full cost This follows the 2024 coverage restrictions that ended new Zepbound coverage BCBS North Dakota Coverage for weight-loss drugs including GLP-1s will be removed from most large employer plans in 2026
Factors to Consider When Choosing Needle Size Selecting the right needle gauge and length depends on several variables, including: Patient Age and Weight Pediatric patients typically require smaller needles (higher gauge and shorter length)
